Maya Hites

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae

Anaïs Eskenazi, Cédric Lood, Julia M. Wubbolts et al. · Nature Communications · 2022 · 265 citations · Full text

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

George R. Thompson, Àlex Soriano, Oliver A. Cornely et al. · The Lancet · 2022 · 150 citations · Full text

Translational Medicine, Antifungal Agent, Antifungal Agents +6

Elevated β-lactam concentrations associated with neurological deterioration in ICU septic patients.

M Beumier, Giuseppe Stefano Casu, Maya Hites et al. · PubMed · 2015 · 122 citations

Case-Control Study of Drug Monitoring of β-Lactams in Obese Critically Ill Patients

Maya Hites, Fabio Silvio Taccone, Fleur Wolff et al. · Antimicrobial Agents and Chemotherapy · 2012 · 115 citations · Full text

Severe Sepsis, Pharmacotherapy, Case-control Study +17